Factors that impact decision making among rheumatologists in the initiation of treatment for hypertension in rheumatoid arthritis

Journal of Clinical Rheumatology

Volumn 13, Issue 6, 2007, Pages 307-312

  Nguyen Oghalai, Tracy U ^a,b   Hunnicutt, Sonya E ^a   Smith, Sarah Toombs ^a   Maganti, Rashmi ^a   McNearney, Terry A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Clinical practice guidelines; Decision analysis; Primary care; Surveys

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIVARIATE ANALYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL SPECIALIST; NORMAL HUMAN; PATIENT RIGHT; PERCEPTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SEX RATIO; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DECISION MAKING; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; QUESTIONNAIRES; RHEUMATOLOGY; RISK FACTORS; UNITED STATES;

EID: 37849013886     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318156bcc2     Document Type: Article

References (26)

1. Giles JT, Post W, Blumenthal RS, et al. Therapy insight: managing cardiovascular risk in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol. 2006;2:320-329.
2. Kaplan MJ. Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol. 2006;18:289-297.
3. del Rincon I, Freeman GL, Haas RW, et al. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum. 2005;52:3413-3423.
4. Mikuls TR, Saag KG. Comorbidity in rheumatoid arthritis. Rheum Dis Clin NorthAm. 2001;27:283-303.
5. Berkanovic E, Hurwicz ML. Rheumatoid arthritis and comorbidity. J Rheumatol. 1990;17:888-892.
6. Myllykangas-Luosujarvi R, Aho K, Kautiainen H, et al. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol. 1995;22:1065-1067.
7. del Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44:2737-2745.
8. McEntegart A, Capell HA, Creran D, et al. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology. (Oxford) 2001;40:640-644.
9. Schoenborn CA, Vickerie JL, Powell-Griner E. Health characteristics of adults 55 years of age and over: United States, 2000-2003. Advance data from vital and health statistics, April 11, 2006;370:1-31. Available at: http://www.cdc.gov/nchs/data/ad/ad370.pdf. Accessed August 30, 2006.
10. Monitoring drug therapy in rheumatoid arthritis. In: Klippel JH, ed. Primer on Rheumatic Diseases. 12th ed. Atlanta, GA: Arthritis Foundation; 2001:650-651.
11. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
12. Nguyen-Oghalai TU, Wassel Fyr C, Criswell LA. Inadequate detection and treatment of hypertension in rheumatoid arthritis. Arthritis Rheum. 2003;48:S320.
13. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines, Guidelines for the Management of Rheumatoid Arthritis 2002 Update. Arthritis Rheum. 2002;46:328-346.
14. Dillman DA. Mail and telephone surveys: the total design method. In: Fowler FJ, ed. Survey Research Methods. 2nd ed. New York/San Diego: Wiley/Sage; 1978.
15. Wolfe F, Albert DAA, Pincus T. A survey of United States Rheumatologists Concerning Effectiveness of Disease-Modifying Antirheumatic Drugs and Prednisone in the Treatment of Rheumatoid Arthritis. Arthritis Care Res. 1998;11:375-380.
16. Kamal KM, Madhavan SS, Hornsby JAA, et al. Use of tumor necrosis factor inhibitors in rheumatoid arthritis: a national survey of practicing United States Rheumatolosists. Joint Bone Spine. 2006;73:718-724.
17. 2006 Membership Demographics, Personal Communication with Steve Blevins, Information Services, ACR. Available at: www.rheumatology.org.
18. Weinblatt ME. The best of times, the worst of times: rheumatology 2001. Arthritis Rheum. 2002;46:567-573.
19. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
20. Margolis KL, Rolnick SJ, Fortman KK, et al. Self-reported hypertension treatment beliefs and practices of primary care physicians in a managed care organization. Am J Hypertens. 2005;18(4 Pt 1):566-571.
21. Position Statement - Presented by Committee on Rheumatologic Care "The Rheumatologist as Principal Care Physician," (approved 03/13/04) ACR Publications: Position Statement. Available at: www.rheumatology.org.
22. MacLean CH. Louie R. Leake B, et al. Quality of care for patients with rheumatoid arthritis JAMA. 2000;284:984-992.
23. Leal S, Glover JJ, Herrier RN, et al. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care. 2004;27:2983-2984.
24. Clark CM Jr, Fradkin JE, Hiss RG, et al. The National Diabetes Education Program, changing the way diabetes is treated: comprehensive diabetes care. Diabetes Care. 2001;24:617-618.
25. Ho M, Marger M, Beart J, et al. Is the quality of diabetes care better in a diabetes clinic or in a general medicine clinic? Diabetes Care. 1997;20:472-475.
26. Adams AS, Soumerai SB, Lomas J, et al. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care. 1999;11:187-192.